This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wahlström, G. M. Articles by Vennström, B. Search for Related Content PubMed PubMed Citation Articles by Wahlström, G. M. Articles by Vennström, B.

Requirements for Repression of Retinoid X Receptor by the Oncoprotein P75^gag-v-erbA and the Thyroid Hormone Receptors

Department of Cellular and Molecular Biology Laboratory for Developmental Biology Karolinska Institute S-171 77 Stockholm, Sweden

The oncogenic counterpart of thyroid hormone receptor- (TR), denoted P75^gag-v-erbA, has served as a paradigm for the ability of TRs to repress basal levels of transcription. We show here that the retinoid X receptor (RXR), when activated by its specific ligand SR11237, is repressed by both the normal TR and the P75^gag-v-erbA. The repression caused by the two proteins is distinct and dependent on both the cell type and the hormone-response element through which RXR acts. In HeLa cells only TR repressed efficiently through the palindromic 2xIR0 element, whereas the proteins were equally efficient in JEG cells. This demonstrates that proteins distinct in the two cell types mediate the repression. RXR-dependent induction via the natural response element of the cellular retinol-binding protein (CRBPII) gene was likewise (50%) repressed by TR, whereas P75^gag-v-erbA did not repress during the same conditions. Furthermore, P75^gag-v-erbA and its variants v-erbA^td359 (lacking repressing activity on TR) and v-erbA^r12 (a highly active repressor of TR) efficiently repressed induction by a hybrid protein consisting of the DNA- binding domain of Gal4 and the ligand-binding region of RXR. The viral proteins did not, however, associate with RXR unless the two partners were allowed to heterodimerize upon binding to a specific response element, such as the 2xIR0 element or that of the CRBPII gene. In conclusion, we suggest that the efficient repression seen with the the 2xIR0 element is due to heterodimerization of TR or the viral oncoproteins with RXR and a concomitant inhibition of binding of the RXR-specific ligand that results in an inability of RXR to attract a cell type-specific cofactor. In addition, the data suggest that the interaction between RXR and P75^gag-v-erbA on the CRBPII element is too weak to inhibit RXR from binding a ligand and therefore also to repress.

This article has been cited by other articles:

				G. M. C. Bonamy, A. Guiochon-Mantel, and L. A. Allison Cancer Promoted by the Oncoprotein v-ErbA May Be Due to Subcellular Mislocalization of Nuclear Receptors Mol. Endocrinol., May 1, 2005; 19(5): 1213 - 1230. [Abstract] [Full Text] [PDF]